LIPOPROTEIN DISORDER
Clinical trials for LIPOPROTEIN DISORDER explained in plain language.
Never miss a new study
Get alerted when new LIPOPROTEIN DISORDER trials appear
Sign up with your email to follow new studies for LIPOPROTEIN DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug Kylo-11 aims to tackle stubborn heart disease risk factor
Disease control Recruiting nowThis phase 2 trial tests Kylo-11, an experimental drug, in 204 adults with heart disease and high levels of lipoprotein(a) – a genetic risk factor for heart attacks and strokes. Participants receive either Kylo-11 or a placebo injection for about a year. The main goal is to see i…
Matched conditions: LIPOPROTEIN DISORDER
Phase: PHASE2 • Sponsor: Kylonova (Xiamen) Biopharma co., LTD. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New study probes hidden heart risk from common blood fat
Knowledge-focused Recruiting nowThis study looks at how a type of fat in the blood called lipoprotein(a), or Lp(a), affects the stiffness of arteries, the health of blood vessel linings, and the heart's ability to pump. Researchers will follow 300 adults for one year, measuring these factors and tracking heart …
Matched conditions: LIPOPROTEIN DISORDER
Sponsor: University of Athens • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC